Candel Therapeutics 주식 (NASDAQ: CADL)

에 대한 최신 뉴스 Candel Therapeutics (NASDAQ:CADL) 주식

Candel Therapeutics

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Equities

News

Markets

CADL

NVDA

PLTR

TSLA

미국 주식 시장은 목요일에 하락하며, 다우존스 지수는 1.35% 하락한 38,596.98에 도달했다. NASDAQ와 S&amp;P 500도 각각 1.4% 하락한 16,049.08과 1.23% 하락한 5,147.21을 기록했다. 전체 시장의 하락에도 불구하고, 일부 종목은 소매 트레이더와 투자자들의 주목을 끌었다.



하루 내내 소매 트레이더와 투자자들의 관심을 끌은 주요 주식은 다음과

목요일의 주요 주식: 포드, 캔들 테라퓨틱스, 엔비디아, 팔란티어, 테슬라

Candel Therapeutics Inc

Cadeler AS

On Friday, Tesla and SpaceX CEO Elon Musk said that they have been granted permission to deliver Starlink terminals and supplies to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41105907/hurricane-helene-shutters-baxter-internationals-key-manufacturing-hub-in-north-caro">disaster-stricken areas in North Carolina</a>. However, the approval allegedly met some resistance initially.
What Happened:&nbsp;Musk took to X, formerly Twitter, and complained that SpaceX engineers were barred by the Federal Emergency Management Agency or FEMA from delivering Starlink terminals and&nbsp;supplies.
&#8220;SpaceX engineers are trying to&nbsp;deliver Starlink terminals &amp;&nbsp;supplies to devastated areas in&nbsp;North Carolina right now and&nbsp;FEMA is both failing to&nbsp;help AND won't let others&nbsp;help. This is unconscionable,&#8221; he said.
He also shared a video showing the extent of the devastation, with&nbsp;roads, houses, electricity, water supply, and ground internet connections destroyed.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41136119/vance-vs-walz-flash-poll-picks-this-candidate-as-tuesdays-debate-winner-but-he-falls-short-in-favora?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Vance Vs. Walz: Flash Poll Picks This Candidate As Tuesday&#8217;s Debate Winner, But He Falls Short In Favorability Rating</a>
He further criticized FEMA for not allowing the SpaceX team to land and deliver critical supplies, adding, &#8220;My blood is boiling.&#8221;
However, in a later update, Musk confirmed that SpaceX had finally received the necessary approval from FEMA to proceed with the delivery of the Starlink terminals and supplies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Approval received
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842350511082610925?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Musk also clashed with Department of Transportation Secretary Pete Buttigieg over allegations that <a href="https://www.benzinga.com/news/24/10/41195165/pete-buttigieg-and-elon-musk-clash-over-hurricane-aid-flight-claims">federal authorities hindered flights</a> delivering aid to Hurricane Helene victims.
&#8220;The level of belligerent government incompetence is staggering,&#8221; he stated earlier.
Meanwhile, the White House also&nbsp;<a href="https://www.benzinga.com/news/24/10/41195085/white-house-counters-gop-accusations-of-fema-funds-misuse-denies-disaster-relief-funding-was-used-fo">refuted GOP claims</a>&nbsp;of FEMA funds mismanagement following the hurricane. &#8220;No disaster relief funding at all was used to support migrants housing and services. None. At. All.&#8221;
Earlier, President Joe Biden praised the end of a port strike&nbsp;that threatened to disrupt the U.S. economy, highlighting its <a href="https://www.benzinga.com/news/24/10/41177525/biden-praises-end-of-port-strike-highlights-importance-for-hurricane-helene-recovery-collective-barg">importance for Hurricane Helene&#8217;s recovery</a>.
Previously, former President Donald Trump claimed credit for the deployment of Starlink satellites to aid communication restoration in areas affected by the hurricane. However, <a href="https://www.benzinga.com/news/24/10/41110218/trump-says-he-spoke-with-elon-musk-for-starlink-deployment-to-aid-hurricane-helene-affected-areas-bu">he was contradicted by FEMA</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/10/41151338/biden-the-master-oil-trader-part-iv-president-loads-up-on-millions-of-barrels-to-refill-emerg?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden The Master Oil Trader Part IV? President Loads Up On Millions Of Barrels To Refill Emergency Stash In &#8216;One Of The Best Oil Trades In History&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Wikimedia

Politics

Tech

Elon Musk Said His Blood Was 'Boiling' After FEMA Allegedly Didn't Allow SpaceX Engineers To Deliver Starlink Terminals And Supplies To Hurricane Helene Victims, But Now They've Received Approval

Taiwan-based&nbsp;Novatek&nbsp;is gearing up to mass-produce OLED displays a new technology that could significantly influence the design of future Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) iPhones.
What Happened: On Friday, Novatek announced a plan to initiate&nbsp;mass production of OLED displays&nbsp;that incorporate&nbsp;Touch and Display Driver&nbsp;Integration or TDDI technology by the second quarter of 2025, <a href="https://www.digitimes.com/news/a20241004PD206/novatek-apple-tddi-ddi-taiwan.html">reported</a> DigiTimes.
Apple might be among the first clients for Novatek&#8217;s innovative technology, although this remains speculative at this point. 
The projected production timeline for Novatek&#8217;s TDDI displays aligns with the anticipated launch of next-generation iPhone displays in 2025.
See Also:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41149666/nvidias-blackwell-gpu-sets-new-ai-benchmark-with-over-100-system-configurations-ana?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s Blackwell GPU Sets New AI Benchmark With Over 100 System Configurations, Analyst Says</a>
TDDI technology could enable the creation of slimmer OLED displays by merging&nbsp;touch and display driver layers,&nbsp;making it a potential fit for the speculated ultra-thin &#8220;iPhone 17 Air.&#8221;
According to the report, the Cupertino, California-based tech giant might initially implement it in lower-volume products like&nbsp;future iPad and Apple Watch&nbsp;models.
The technology could also find application in&nbsp;a long-rumored foldable iPhone or&nbsp;iPad.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Apple is rumored to be developing a thinner version of the iPhone 17, expected to launch in 2025. This model, potentially featuring a sleeker design, could attract more <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40332493/apples-thinner-iphone-17-air-with-sleeker-design-could-be-a-game-changer-says-promi">customers to upgrade their devices</a>.
Previously, it was also reported that while the iPhone 16 may <a href="https://www.benzinga.com/markets/equities/24/08/40304265/apples-iphone-16-may-not-fuel-a-gold-rush-of-purchases-but-next-iteration-will-likely-return-fla">not offer a radical redesign</a>, the next iteration could return the flagship product to meaningful growth.
Meanwhile, T-Mobile U.S. Inc. CEO Mike Sievert reported encouraging sales numbers for the new iPhone model last month, showing a strong launch despite initial concerns about demand.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41042433/elon-musks-x-suspends-5-3m-accounts-flags-10-6m-posts-in-first-transparency-report-amid-user-and-adv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s X Suspends 5.3M Accounts, Flags 10.6M Posts In First Transparency Report Amid User And Advertiser Decline</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Apple

AAPL

Apple Might Have Just Found The Technology To Power Its Thin iPhone 17 Air Display

In a continued shift away from its cashierless Go convenience stores, Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has reportedly shuttered three more locations in New York last week.
What Happened: Amazon has been steadily reducing its Go stores that use the &#8220;Just Walk Out&#8221; technology, with the latest closures, the total number of Go stores has come down to 17 nationwide, <a href="https://techcrunch.com/2024/10/04/amazon-closes-more-of-its-cashierless-convenience-stores/">reported</a> TechCrunch (<a href="https://www.theinformation.com/briefings/amazon-closes-three-more-go-convenience-stores">via</a> The Information) on Friday.
Last year in March also, the <a href="https://www.benzinga.com/news/23/03/31252375/amazon-prepares-to-cut-more-fluff-shut-8-amazon-go-stores-in-seattle-san-francisco-nyc">company had shut down eight</a> Go stores in Seattle, San Francisco, and New York.
Earlier this year, the company removed the&nbsp;Just Walk Out technology from&nbsp;its grocery stores, focusing&nbsp;more on smaller grab-and-go shops. It also opened a new Go store in Washington.
The e-commerce giant also continues to license the&nbsp;Just Walk Out technology to&nbsp;third-party convenience stores.
See Also:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41149666/nvidias-blackwell-gpu-sets-new-ai-benchmark-with-over-100-system-configurations-ana?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s Blackwell GPU Sets New AI Benchmark With Over 100 System Configurations, Analyst Says</a>
Why It Matters: In 2016, Amazon launched its Just Walk Out feature, enabling customers to scan a QR code when entering a store, pick up items, and leave without going through a traditional checkout.
The system relies on cameras, sensors, and a remote team monitoring shoppers to accurately track purchases and complete transactions.
However, the experimental system has faced several challenges, including long delays in finalizing transactions—sometimes taking hours—and the high costs involved in installing the necessary cameras and sensors at each location.
Earlier this year, it was reported that Amazon replaced this <a href="https://www.benzinga.com/news/24/04/38055211/amazon-to-replace-just-walk-out-checkout-technology-with-smart-dash-carts">technology with a &#8220;smart-cart&#8221;</a> system called Dash Cart in its grocery stores.
Despite the closures, Amazon continues to focus on profitable ventures and efficiency gains. Earlier this month, Morgan Stanley analyst Brian Nowak reiterated <a href="https://www.benzinga.com/news/24/10/41169322/amazons-profitable-essential-merchandise-efficiency-gains-set-to-drive-growth-analyst">Amazon with an Overweight rating</a>, highlighting the company&#8217;s growth potential.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41087674/openais-searchgpt-set-to-disrupt-googles-search-empire-as-former-engineer-sounds-alarm-on-deteriorat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">OpenAI&#8217;s SearchGPT Set To Disrupt Google&#8217;s Search Empire As Former Engineer Sounds Alarm On Deteriorating User Experience Amid Rising Competition</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Wikimedia

Media

AMZN

Amazon Shutters 3 More Cashierless Go Stores In New York: Report

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is on the verge of reaching a new all-time high, according to a prominent crypto analyst. The analyst suggests that Bitcoin must break through a significant resistance level to achieve this milestone.
What Happened: Bitcoin could reach a new peak if it surpasses the $64,000 resistance level.
Inmortal, a well-known trader, shared with his 216,300 followers on X that Bitcoin&#8217;s recent decline from around $66,000 to $60,000 might be forming a local bottom. He is considering going long on BTC if it demonstrates a swing failure pattern near $60,000 or gains acceptance above $63,000.
"Breakout above $64,000 = New ATH."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Breakout above 64k = New ATH<a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/mUvDN5sTyi">pic.twitter.com/mUvDN5sTyi</a>
&mdash; Inmortal (@inmortalcrypto) <a href="https://twitter.com/inmortalcrypto/status/1842200703810633835?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, another analyst, Kaleo, predicts a short-term dip to approximately $57,000 or $58,000 before a rebound. He expects Bitcoin to rise gradually over the next month, especially after the presidential election, advising traders to accumulate during this period.
"Bitcoin. Still looking like a quick little chop to $57,000 or $58,000, followed by a grind higher the rest of the month into a full send post election."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> / <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Still looking like a quick little chop to 57 / 58, followed by a grind higher the rest of the month into a full send post election <a href="https://t.co/QX3wGjPNJQ">pic.twitter.com/QX3wGjPNJQ</a>
&mdash; K A L E O (@CryptoKaleo) <a href="https://twitter.com/CryptoKaleo/status/1841839257096208721?ref_src=twsrc%5Etfw">October 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41100361/remember-sbfs-i-didnt-stash-billions-away-the-latest-ftx-repayment-update-may-have-other-i?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Remember SBF&#8217;s &#8216;I Didn&#8217;t Stash Billions Away&#8217;? The Latest FTX Repayment Update May Have Other Ideas</a>
Why It Matters: The potential for Bitcoin to hit new highs comes amid a backdrop of strong market performance. Recently, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41191566/bitcoin-ethereum-dogecoin-end-the-week-with-strong-gains-summer-lull-seasonality-over-q4-b">cryptocurrency markets</a> have been buoyed by positive labor market data, signaling the end of the summer lull and the start of a bullish fourth quarter.
Additionally, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41185013/bitcoin-rebounds-above-61-500-and-80k-is-more-likely-than-40k-says-top-technical-analyst">technical analysts</a> have noted Bitcoin&#8217;s rebound above $61,500, suggesting that $80,000 is more likely than $40,000. This aligns with the current bullish sentiment, despite some bearish low-timeframe actions.
Furthermore, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41172369/bitcoin-not-a-safe-haven-but-rising-trump-odds-could-fuel-a-rally-standard-chartered">Standard Chartered</a> has highlighted Bitcoin&#8217;s role as a hedge against traditional financial system issues, rather than geopolitical tensions. This perspective reinforces the notion that Bitcoin&#8217;s price movements are more influenced by financial market dynamics than geopolitical events.
Price Action: At the time of writing, Bitcoin is trading at $62,120, showing a 1.5% increase over the past 24 hours, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41166146/would-bitcoin-drop-if-a-war-in-the-middle-east-breaks-out-yes-but-theres-a-catch?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Would Bitcoin Drop If A War In The Middle East Breaks Out? Yes, But There&#8217;s A Catch</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Could Hit New All-Time High If It Breaks Above This Resistance Level, Says Analyst

Elon Musk, CEO of SpaceX, has stated that the future of human exploration on Mars is contingent on the <a href="https://www.benzinga.com/topic/2024-election">re-election of former President</a> Donald Trump and the reduction of what he calls &#8220;smothering regulations."
What Happened: Musk, who has thrown his weight behind Trump, endorsed him yet again in the backdrop of <a href="https://www.benzinga.com/news/24/09/41018400/spacex-hits-back-at-faa-chief-for-pinning-starship-delays-on-safety-concerns-every-statement-he-made">SpaceX's struggles</a> with the Federal Aviation Administration, or FAA.
&#8220;Unless Trump wins and we get rid of the mountain of smothering regulations (that have nothing to do with safety!), humanity will never reach Mars. This is existential.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Unless Trump wins and we get rid of the mountain of smothering regulations (that have nothing to do with safety!), humanity will never reach Mars. This is existential. <a href="https://t.co/I9zZuzRvHi">https://t.co/I9zZuzRvHi</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842250303762051263?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41157836/teslas-cybercabs-could-be-a-potential-ride-sharing-disruptor-says-analyst-heres-wha?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla&#8217;s &#8216;Cybercabs&#8217; Could Be A Potential Ride-Sharing Disruptor, Says Analyst</a>
This comes amid escalating tensions between SpaceX and FAA, with Musk <a href="https://www.benzinga.com/news/24/09/41041586/spacex-ceo-elon-musk-calls-for-resignation-of-faa-administrator-mike-whitaker">recently calling for the resignation</a> of FAA chief Mike Whitaker.
Musk&#8217;s company has criticized Whitaker for his defense of delays in SpaceX&#8217;s Starship launch vehicle, claiming that &#8220;every statement he made was incorrect.&#8221;
Why It Matters: The relationship between SpaceX and the FAA has been strained, with Musk accusing the FAA of favoritism towards Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) and proposing a <a href="https://www.benzinga.com/markets/equities/24/09/40912464/elon-musk-accuses-faa-of-fining-spacex-over-nonsense-that-doesnt-affect-safety-amazingly-no-star">$633,009 fine on SpaceX</a> for regulatory violations.
Whitaker has defended the FAA&#8217;s actions, citing safety concerns and regulatory compliance as reasons for the delay in SpaceX&#8217;s Starship launch. He also stated that <a href="https://www.benzinga.com/news/24/09/41016988/spacex-in-violation-of-texas-federal-law-on-some-matters-says-faa-agency-hits-back-at-elon-musks-roc">SpaceX did not adhere</a> to permitting and licensing requirements, which Musk criticized as obstructive.
These ongoing disputes have led Musk to argue that the future of space exploration depends on a political climate that favors deregulation. His recent tweet suggests that he sees a Trump victory as a necessary condition for this to happen.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41161763/european-telecom-giants-threaten-legal-action-against-elon-musks-starlink-over-potential-fcc-rule-ch?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">European Telecom Giants Threaten Legal Action Against Elon Musk&#8217;s Starlink Over Potential FCC Rule Change</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

SPACE

General

Elon Musk Says 'Humanity Will Never Reach Mars' Unless Trump Wins: 'This Is Existential'

Former Treasury Secretary Larry Summers has expressed disapproval of the Federal Reserve&#8217;s decision to <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead">cut interest rates last month</a>, terming it a misstep in the face of the latest US job growth data.
What Happened: On Friday, Summers took to X, formerly Twitter, and voiced his disagreement with the Federal Reserve&#8217;s decision to slash interest rates by 50 basis points in September.
He labeled this action as a &#8220;mistake,&#8221; particularly in light of the recent data that shows <a href="https://www.benzinga.com/trading-ideas/previews/24/10/41170128/jobs-report-preview-could-september-labor-data-shift-feds-interest-rate-path">U.S. job growth</a> exceeding all predictions.
&#8220;Today&#8217;s employment report confirms suspicions that we are in a high neutral rate environment where responsible monetary policy requires caution in rate cutting,&#8221; he said.
See Also: <a href="https://www.benzinga.com/news/24/08/40301145/lawrence-summers-calls-for-sec-investigation-into-unprecedented-vix-movement">Lawrence Summers Calls For SEC Investigation Into Unprecedented VIX Movement</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today's employment report confirms suspicions that we are in a high neutral rate environment where responsible monetary policy requires caution in rate cutting. With the benefit of hindsight, the 50 basis point cut in September was a mistake, though not one of great consequence.…
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1842214555562258679?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41184080/us-economy-adds-254-000-new-jobs-in-september-smashes-expectations-unemployment-f">September jobs report</a> exceeded expectations, showing a 254,000 increase in U.S. payrolls and a surprising drop in the unemployment rate to 4.1%.
Wage growth also outpaced predictions, climbing 0.4% from the previous <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41187740/blowout-september-jobs-report-spurs-reactions-6-economists-say-aggressive-fed-rat">month and 4% over the past</a> year.
Joseph Brusuelas, principal and chief economist at RSM US LLP, highlighted the strong wage increases and dismissed recession concerns, pointing instead to a &#8220;mid-cycle economic expansion.&#8221;
Aditya Bhave, U.S. economist at BofA Securities, adjusted his November forecast to smaller rate cuts (25 basis points) due to the robust economic data.
Bhave predicted a terminal rate of 3.0%-3.25%, with the potential for it to rise further, given the unexpectedly strong productivity growth.
Before the September rate cut, Federal Reserve Chairman Jerome Powell had stated that future interest rate cuts would hinge on economic data. His comments at the time added <a href="https://www.benzinga.com/news/24/09/41102248/stocks-slip-as-powell-says-future-interest-rate-cuts-hinge-on-data-economy-is-in-solid-shape-we-inte">uncertainty to the market</a>, causing stocks to slip.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39875424/larry-summers-biden-quitting-shifts-focus-to-trumps-dishonesty-demagoguery-and-dangerousness-warns-e">Larry Summers: Biden Quitting Shifts Focus To Trump&#8217;s &#8216;Dishonesty, Demagoguery, And Dangerousness&#8217; — Warns Ex-President&#8217;s Policies Will &#8216;Undermine Economic Security Of Tens Of Millions&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Economics

Federal Reserve

Former Treasury Secretary Larry Summers Slams Fed's September Rate Cut Saying It Was A Mistake: 'Today's Employment Report Confirms Suspicions That...'

Department of Transportation Secretary Pete Buttigieg took aim at Elon Musk on Friday over allegations that federal authorities hindered flights delivering aid to <a href="https://www.benzinga.com/topic/hurricane-helene">Hurricane Helene</a> victims.
What Happened: Musk posted a screenshot implying that airspace was &#8220;shut down&#8221; and the Federal Aviation Administration (FAA) was &#8220;throttling flights.&#8221;
Musk voiced his frustration, stating, &#8220;The level of belligerent government incompetence is staggering!!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just received this text 20 mins ago. The level of belligerent government incompetence is staggering!! <a href="https://t.co/wWbBR7FfUo">pic.twitter.com/wWbBR7FfUo</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842252268856324160?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In response, Buttigieg refuted these claims, asserting that the FAA does not obstruct legitimate rescue and recovery flights. He extended an invitation to Musk to discuss any issues directly, saying, &#8220;If you're encountering a problem give me a call.&#8221;
Following their public exchange, Musk expressed gratitude for a private conversation with Buttigieg, indicating a desire to resolve the matter. &#8220;Thanks for the call. Hopefully, we can resolve this soon,&#8221; Musk wrote, though the details of their discussion remain undisclosed.
See Also: <a href="https://www.benzinga.com/news/24/10/41157285/elon-musks-mom-chimes-in-after-son-says-he-cant-handle-4-years-of-seeing-and-hearing-kamala-harris-a?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s Mom Chimes In After Son Says He Can&#8217;t Handle 4 Years Of &#8216;Seeing And Hearing&#8217; Kamala Harris And Tim Walz</a>
Musk also posted a video showing SpaceX engineers trying to deliver Starlink terminals.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">SpaceX engineers are trying to deliver Starlink terminals &amp; supplies to devastated areas in North Carolina right now and <a href="https://twitter.com/fema?ref_src=twsrc%5Etfw">@FEMA</a> is both failing to help AND won't let others help. This is unconscionable!! They just took this video a few hours ago, where you can see the level of… <a href="https://t.co/abpOsfNenF">pic.twitter.com/abpOsfNenF</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842284913279586447?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The backdrop of this exchange is the ongoing recovery efforts following Hurricane Helene, which has significantly impacted the region.
<a href="https://www.benzinga.com/news/24/10/41138209/elon-musks-spacex-to-give-free-starlink-access-to-hurricane-helene-victims">Musk&#8217;s SpaceX</a> has been proactive in offering free Starlink access to affected areas, aiming to facilitate communication and aid efforts. This move was part of a broader initiative to deploy a software update ensuring Starlink systems operate without payment in hurricane-affected zones.
Furthermore, the hurricane season has been notably active, with <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41145534/hurricane-helene-adds-to-most-active-quarter-for-power-outages-driving-back-up-gene">Hurricane Helene</a> contributing to widespread power outages, affecting millions. This has driven demand for backup generators, as noted by analysts observing increased consumer interest in such products.
Amidst these challenges, the <a href="https://www.benzinga.com/news/24/10/41195085/white-house-counters-gop-accusations-of-fema-funds-misuse-denies-disaster-relief-funding-was-used-fo">White House</a> has been countering accusations from Republicans regarding the misuse of FEMA funds in the aftermath of the hurricane. These claims have been strongly denied, with officials labeling them as falsehoods.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41195023/kamala-harris-meets-arab-american-leaders-angry-at-us-for-supporting-israel-in-ongoing-conflict-in-g">Kamala Harris Meets Arab American Leaders Angry At US For Supporting Israel In Ongoing Conflict In Gaza: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Gage Skidmore via Flickr

Pete Buttigieg And Elon Musk Clash Over Hurricane Aid Flight Claims

The White House has refuted Republican claims of Federal Emergency Management Agency (FEMA) funds mismanagement following Hurricane Helene.
What Happened: On Friday, Andrew Bates, the senior deputy press secretary, issued a memo accusing Republicans of propagating &#8220;bald-faced lies&#8221; about the post-Hurricane Helene cleanup efforts, <a href="https://thehill.com/homenews/administration/4916014-federal-response-criticized/">reported</a> The Hill.
Republicans, including former President Donald Trump, have claimed&nbsp;that disaster relief funding was&nbsp;spent on migrants, criticizing the administration&#8217;s hurricane response.
Bates denied these allegations, saying, &#8220;No disaster relief funding at all was used to support migrants housing and services. None. At. All.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41156066/elon-musk-cant-contain-his-joy-after-california-deepfakes-law-supported-by-gavin-newsom-blocked-by-c?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Can&#8217;t Contain His Joy After California Deepfakes Law Supported By Gavin Newsom Blocked By Court: &#8216;Yay!&#8217;</a>
He stated that Congress appropriates the funding for migrant support to Customs &amp; Border Protection, and FEMA merely administers it.
Bates also noted&nbsp;that FEMA has already provided&nbsp;over&nbsp;$45 million in direct financial&nbsp;assistance to individuals and families&nbsp;affected by the storm. He cautioned against the potential harm of spreading false information, especially&nbsp;when people are in need.
On the same day, FEMA also released a fact-checking page, confirming that &#8220;no money has been diverted&#8221; and that it has sufficient funds&nbsp;for immediate response and recovery&nbsp;needs.
Why It Matters: Hurricane Helene, which hit on Sept. 26, caused significant damage and <a href="https://www.benzinga.com/news/24/10/41126631/hurricane-helene-devastation-the-latest-on-damage-companies-affected">left nearly 800,000 people</a> without power. The storm claimed more than 130 lives and caused widespread power outages, affecting over two million customers of Duke Energy Corp.
As a result of the hurricane, there was a surge in <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41145534/hurricane-helene-adds-to-most-active-quarter-for-power-outages-driving-back-up-gene">demand for backup and portable</a> power generators.
President Joe Biden has urged Congress to reconvene from recess to approve more funding for recovery efforts, though lawmakers aren't scheduled to return until Nov. 12.
His administration has already sent over 4,800 federal personnel to aid in the response, and the president has authorized the deployment of up to 1,000 troops to assist with North Carolina's recovery, the report noted.
Biden visited North Carolina on Wednesday, followed by trips to Florida and Georgia on Thursday to assess the damage and meet with local leaders.
Previously, Republican presidential nominee Trump allegedly took credit for the deployment of Elon Musk-led Starlink satellites to aid communication restoration in areas affected by Hurricane Helene.
However, FEMA contradicted his statement, saying that the decision was already in <a href="https://www.benzinga.com/news/24/10/41110218/trump-says-he-spoke-with-elon-musk-for-starlink-deployment-to-aid-hurricane-helene-affected-areas-bu">place before Trump's alleged</a> involvement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41136119/vance-vs-walz-flash-poll-picks-this-candidate-as-tuesdays-debate-winner-but-he-falls-short-in-favora?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Vance Vs. Walz: Flash Poll Picks This Candidate As Tuesday&#8217;s Debate Winner, But He Falls Short In Favorability Rating</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Flickr

White House Counters GOP Accusations Of FEMA Funds Misuse, Denies Disaster Relief Funding Was Used For Migrant Housing: 'Bald-Faced Lies'

Chinese electric vehicle startup Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) announced late Friday that it has struck a partnership with one of its strategic investors to foray into the <a href="https://www.benzinga.com/markets/asia/24/06/39213251/asia-mena-gaming-markets-reach-85-5b-in-2023-see-future-projections">Middle East and North Africa</a>.
What Happened: Nio has tied up with Abu Dhabi-based CYVN Holdings to launch the Nio MENA in a bid to launch Nio-branded vehicles and vehicles from its subsidiary in the region, the Shanghai-based company said in a statement. This, according to the company, will expand its footprint and integrate further into the &#8220;global smart EV ecosystem.&#8221;
CYVN Holdings will support Nio with strategic investments for the expansion, which will start with UAE.
The company also plans to establish a state-of-the-art R&amp;D center in Abu Dhabi, the capital city of UAE. This center will focus on &#8220;autonomous driving and artificial intelligence advancements, reinforcing NIO's global R&amp;D capabilities and fostering technological innovation in the MENA region.&#8221;
Nio and CYVN Holdings plan to collaborate on a new EV project that will involve research, manufacturing, and future product launches. The EV startup would also work with its partners in Egypt to expand EV manufacturing in the country.
In <a href="https://www.benzinga.com/markets/asia/23/12/36281426/nio-stock-up-premarket-after-securing-2-2b-strategic-investment" target="_blank" rel="noreferrer noopener">December Nio closed a $2.2 billion equity investment from</a>&nbsp;CYVN Investments RSC Ltd.
 Jassem Mohamed Obaid Bu Ataba Alzaabi, Chairman of CYVN Holdings, said, &#8220;This partnership is a testament to our mutual commitment to fostering the strength of our strategic collaborations and achieving transformative goals in the smart mobility sector.&#8221;
Nio&#8217;s founder, Chairman and CEO William Li said, &#8220;Our collaboration with CYVN Holdings is a cornerstone in our strategy to enhance global accessibility to smart electric vehicles and to push the boundaries of technological innovation.&#8221;
See Also: <a href="https://www.benzinga.com/money/best-electric-vehicle-stocks">Best EV Stocks</a>
Why It&#8217;s Important: Nio is a manufacturer of premium EVs and it has recently entered the low-end of the market with its Onvo brand. Deliveries of the first vehicle launched by the sub-brand, codenamed&nbsp;L60, began in late September, and early uptake has been fairly strong.
This week, Nio reported <a href="https://www.benzinga.com/markets/equities/24/10/41114350/chinese-ev-trio-nio-xpeng-li-auto-surge-higher-in-tuesdays-premarket-whats-going-on">strong September and record third-quarter deliveries</a> despite the tough domestic EV market conditions marked by lackluster demand and cutthroat competition. 
In late-September, the company said a trio of domestic strategic investors agreed to invest an aggregate of 3.3 billion yuan ($470.64 million) in cash in its subsidiary Nio China. Nio on its part said it would invest 10 billion yuan (about $1.43 billion) in cash to subscribe to the newly issued shares of Nio China.&nbsp;The latest investments would infuse the much-needed financing to pursue it expansion both in China and overseas. 
Nio&#8217;s prospects in China also appear bright, given China has decided to copiously stimulate the domestic economy, potentially arming consumers with the much-needed cash to splurge.
The company currently sells EVs in European countries such as Norway, Sweden, Germany, and the Netherlands. The MENA partnership comes as the <a href="https://www.benzinga.com/markets/equities/24/10/41182675/tesla-byd-and-other-ev-stocks-to-watch-as-eu-votes-to-approve-tariffs-on-chinese-ev-imports">European Commission has voted in favor of up to 45% tariffs on imported Chinese EVs.</a>
Price Action: Nio ended Friday&#8217;s session up 1.04% at $6.77, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data.</a>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41182930/china-was-tipping-into-a-japan-style-lost-decade-of-deflation-and-stagnation-before-late-septemb">China Was Tipping Into A Japan-Style &#8216;Lost Decade&#8217; Of Deflation And Stagnation Before Late-September Stimulus Announcements, Says Legal Expert</a></li>
</ul>
Photo courtesy: Nio

Tesla Rival Nio Accelerates Global Expansion, To Launch EVs in Middle East Amid EU Tariff Concerns

Democratic Presidential nominee Kamala Harris has reportedly engaged with Arab American and Muslim leaders in Flint, Michigan, amid rising tensions over <a href="https://www.benzinga.com/news/24/06/39562547/us-has-sent-thousands-of-hellfire-missiles-and-2-000-pound-bombs-to-israel-amid-ongoing-war-with-ham">U.S. support for Israel&#8217;s conflicts</a> in Gaza and Lebanon.
What Happened: On Friday, Harris met with representatives from Emgage Action,&nbsp;the American Task Force on&nbsp;Lebanon, and long-time associate Hala Hijazi, reported Reuters, citing two sources.
The meeting is part of a broader effort to reconnect&nbsp;with Muslim and Arab voters,&nbsp;who were instrumental in securing a Democrat win in 2020 but may reconsider their support for Harris in the next election.
Harris addressed the upcoming election and the ongoing Middle East conflicts&nbsp;during the meeting.
She expressed&nbsp;concern over the&nbsp;suffering in Gaza, civilian casualties, and displacement in Lebanon,&nbsp;and discussed efforts to end&nbsp;the war and prevent a regional conflict, the report noted.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41135574/elon-musk-comments-on-jd-vance-tim-walz-debate-after-user-favors-them-over-trump-and-harris-they-wer?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Comments On JD Vance-Tim Walz Debate After User Favors Them Over Trump And Harris: &#8216;They Were Civil&#8217;</a>
Wa&#8217;el Alzayat, CEO of Emgage&nbsp;Action, said they &#8220;asked Vice President Harris to impress upon President Biden the urgency of bringing an immediate end to the violence&#8221; in Gaza and Lebanon.
However, some Arab Americans believe Harris&#8217; reluctance&nbsp;to distance herself from President&nbsp;Biden&#8217;s Middle East policies could cost her in the upcoming election.
A recent poll&nbsp;by the Arab American Institute&nbsp;found Harris and Trump at&nbsp;roughly even levels of support&nbsp;among Arab Americans.
Why It Matters: The meeting comes amidst a backdrop of escalating tensions in the Middle East.
Last month, <a href="https://www.benzinga.com/news/24/09/40920151/china-slams-us-for-shielding-israel-blocking-gaza-ceasefire-efforts-as-war-nears-1-year">China accused the U.S.</a> of shielding Israel and obstructing ceasefire efforts in the Gaza conflict. &#8220;Had the US not shielded one side time and again, multiple resolutions of this council would not have been flagrantly rejected and defied.&#8221;
Later that month,&nbsp;senior U.S. officials <a href="https://www.benzinga.com/news/24/09/40955425/top-us-officials-skeptical-of-israel-hamas-cease-fire-and-hostage-deal-before-bidens-term-ends-repor">expressed skepticism about a ceasefire</a> and hostage-release deal between Israel and Hamas.
Meanwhile, Israel continued its <a href="https://www.benzinga.com/general/politics/24/09/41056542/israel-plans-to-disrupt-arms-delivery-from-iran-to-lebanon-in-motion-as-palestinian-president-cr">military operations in Lebanon and Gaza</a>.
Earlier in the year, Harris had urged Israeli Prime Minister Benjamin Netanyahu to help establish a Gaza ceasefire, a move that was <a href="https://www.benzinga.com/news/24/08/40417063/trump-says-he-encouraged-netanyahu-to-end-gaza-war-while-critizing-kamala-harris-for-demanding-cease">later criticized by</a> Republican presidential candidate Donald Trump.
&#8220;I will give Israel the support that it needs to win but I do want them to win fast,&#8221; Trump reportedly said in August.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/10/41151338/biden-the-master-oil-trader-part-iv-president-loads-up-on-millions-of-barrels-to-refill-emerg?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden The Master Oil Trader Part IV? President Loads Up On Millions Of Barrels To Refill Emergency Stash In &#8216;One Of The Best Oil Trades In History&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Kamala Harris Meets Arab American Leaders Angry At US For Supporting Israel In Ongoing Conflict In Gaza: Report

RPHM

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

CFRA analyst Jonathan Sakraida maintains Ingersoll Rand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IR#NYSE">IR</a>) with a Hold and raises the price target from $85 to $95.

Price Target

Analyst Ratings

CFRA Maintains Hold on Ingersoll Rand, Raises Price Target to $95

Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has outperformed the market over the past 10 years by 19.23% on an annualized basis producing an average annual return of 30.74%. Currently, Tesla has a market capitalization of $798.69 billion. 
Buying $100 In TSLA: If an investor had bought $100 of TSLA stock 10 years ago, it would be worth $1,446.78 today based on a price of $250.01 for TSLA at the time of writing.
<h3>Tesla's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728077784_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Tesla Stock In The Last 10 Years

The phrase "the one percent" gets tossed around a lot in conversations about wealth and inequality, whether in politics, protests, or everyday chats. But what does it mean to be in the top 1%? Let's break it down by income and net worth to get a clearer picture of <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">who's part of this exclusive group.</a>
Don't Miss:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
What Income Puts You in the Top 1%?
To be in the <a href="https://www.benzinga.com/personal-finance/24/07/39652328/your-income-might-be-upper-class-and-you-dont-know-it-heres-the-salary-needed-to-reach-elite-sta">top 1% of earners</a> in the U.S., a household must bring in at least $591,550 a year. For a single individual, the cutoff is $407,500. Remember, these numbers are averages and can vary depending on where you live. For example, earning that much in New York City might not stretch as far as it does in other parts of the country.
The Top 1% by Net Worth
When it comes to net worth, the threshold is even higher. To be part of the top 1% in the U.S., a household's net worth needs to be at least $13.6 million. This measure includes everything you own – homes, investments, savings – minus debts.
Wealth tends to be a lot more unevenly distributed than income. Many households have little to no net worth, while the top tier sits on massive wealth. That's why net worth often gives a clearer picture of someone's financial status than income alone.
Trending: Beating the market through ethical real estate investing' — t<a href="https://www.benzinga.com/money/invest-with-roots">his platform aims to give tenants equity in the homes they live in while scoring 17.17% average annual returns for investors – here&#8217;s how to join with just $100</a>
Income vs. Net Worth: Which Tells the Real Story?
So, which is more important, income or net worth? It depends on what you're trying to measure. Income is great for understanding how much someone earns in a year, but net worth is the better gauge for long-term financial stability and overall wealth. Someone with a high income might not have a high net worth if they spend a lot or have significant debt, while someone with a lower income but solid investments could be much wealthier.
How Many People Are in the 1%?
As of the latest numbers, there are around 1.3 million households and about 1.8 million individual workers who fall into the top 1% in the U.S. That's a small slice of the population but represents a significant share of the country's wealth and income.
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
State-by-State Variations
The income required to be in the top 1% varies significantly across states. For example:
<ul>
<li>Connecticut has the highest threshold at $952,902</li>
<li>Massachusetts follows at $903,401</li>
<li>California comes in third at $844,266</li>
<li>On the lower end, Mississippi has a threshold of just $254,362</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/irs-finalizes-10-year-rule-adv">IRS Finalizes 10-Year Rule For Retirement Withdrawals, Making Things &#8216;Even More Insanely Complicated&#8217;</a>
Understanding <a href="https://www.benzinga.com/personal-finance/24/08/40378006/exactly-how-much-money-do-you-need-to-be-rich-heres-a-look-at-the-numbers">who makes up this elite group</a> isn't just about how much you earn right now but also what you've built over time.&nbsp;
Maybe you're not in the top 1%, or maybe you are – everyone's situation is different. Either way, <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">talking with a financial advisor</a> can be really helpful. They can guide you on where you stand and how to make the best decisions for your financial future, whether you're growing your wealth or looking to manage what you've got.
Read Next:
<ul>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Personal Finance

Are You Rich Enough To Be In The Top 1%? Here's Both The Income And Net Worth You Need to Rank Among The Wealthiest

STOCK RECEIVES 4TH SIGNAL IN LAST 5 TRADING SESSIONS FOR OVER 5% GAIN 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="776" height="797" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM.png" alt="" class="wp-image-1972" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM.png 776w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM-292x300.png 292w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM-768x789.png 768w" sizes="(max-width: 776px) 100vw, 776px" /></figure>
Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:37AM on October 4th, a significant trading signal occurred for Meta Platforms Inc. as it demonstrated a Power Inflow at a price of $582.40. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Meta&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Meta&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for Meta, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data are brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $582.40. The returns on the High price ($596.52) and Close price ($595.94) after the Power Inflow were respectively 2.4% and 2.3%%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Signals

Tradepulse Power Inflow Alert: Meta Platforms Inc. Receives Signal And Climbs Over 2.4% On The Day

Throughout the last three months, 7 analysts have evaluated Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $59.57, a high estimate of $65.00, and a low estimate of $54.00. Witnessing a positive shift, the current average has risen by 17.56% from the previous average price target of $50.67.
<img src="https://www.benzinga.com/files/images/story/2024/1728075764_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Newmont is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Murphy</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$63.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Daniel Major</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>David Coleman</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$58.00</td>
<td>-</td>
</tr>
<tr>
<td>Tanya Jakusconek</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$59.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Jackie Przybylowski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$57.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Matthew Murphy</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Anita Soni</td>
<td>CIBC</td>
<td>Raises</td>
<td>Outperformer</td>
<td>$61.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Newmont. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Newmont compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Newmont's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Newmont's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NEM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Newmont analyst ratings.</a>
<h2>About Newmont</h2>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
<h3>Newmont's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Newmont's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 64.07% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Newmont's net margin excels beyond industry benchmarks, reaching 19.38%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.93%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Newmont's ROA stands out, surpassing industry averages. With an impressive ROA of 1.54%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Newmont's debt-to-equity ratio stands notably higher than the industry average, reaching 0.31. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 7 Analyst Ratings Have To Say About Newmont

During the last three months, 12 analysts shared their evaluations of Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $59.83, along with a high estimate of $70.00 and a low estimate of $40.00. Marking an increase of 13.42%, the current average surpasses the previous average price target of $52.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1728075755_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Lumentum Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simon Leopold</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>George Notter</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Richard Shannon</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Dave Kang</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$69.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Alex Henderson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Lumentum Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Lumentum Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Lumentum Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LITE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lumentum Holdings analyst ratings.</a>
<h2>All You Need to Know About Lumentum Holdings</h2>
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
<h3>Unraveling the Financial Story of Lumentum Holdings</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Lumentum Holdings faced challenges, resulting in a decline of approximately -16.86% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Lumentum Holdings's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -81.9%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lumentum Holdings's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -23.66%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Lumentum Holdings's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -6.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Lumentum Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 2.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LITE

Assessing Lumentum Holdings: Insights From 12 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Quanta Services and provided 12-month price targets. The average target is $297.0, accompanied by a high estimate of $348.00 and a low estimate of $256.00. This upward trend is evident, with the current average reflecting a 3.28% increase from the previous average price target of $287.57.
<img src="https://www.benzinga.com/files/images/story/2024/1728075736_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Quanta Services's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$348.00</td>
<td>$302.00</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$256.00</td>
<td>-</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$280.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$319.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Gus Richard</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$264.00</td>
</tr>
<tr>
<td>Alex Rygiel</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$303.00</td>
<td>$286.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$302.00</td>
<td>$299.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$288.00</td>
<td>$287.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Quanta Services. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Quanta Services compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Quanta Services's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Quanta Services's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PWR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Quanta Services analyst ratings.</a>
<h2>Discovering Quanta Services: A Closer Look</h2>
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under three reportable segments: electric power, renewables infrastructure, and underground utility and infrastructure.
<h3>Quanta Services: A Financial Overview</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Quanta Services showcased positive performance, achieving a revenue growth rate of 10.81% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.36%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.91%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Quanta Services's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.58, Quanta Services adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8 Analysts Assess Quanta Services: What You Need To Know

In the preceding three months, 12 analysts have released ratings for American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.25, a high estimate of $93.00, and a low estimate of $77.00. Observing a 0.08% increase, the current average has risen from the previous average price target of $85.18. 
<img src="https://www.benzinga.com/files/images/story/2024/1728075681_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of American Intl Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$90.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Jennings</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$77.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$86.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$87.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$93.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$87.00</td>
<td>$87.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Intl Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Intl Gr compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for American Intl Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of American Intl Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AIG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on American Intl Gr analyst ratings.</a>
<h2>Delving into American Intl Gr's Background</h2>
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a majority stake.
<h3>American Intl Gr: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining American Intl Gr's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -11.75% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: American Intl Gr's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -60.38%, the company may face hurdles in effective cost management.
Return on Equity (ROE): American Intl Gr's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -9.06%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.12%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.22, American Intl Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: American Intl Gr In The Eyes Of 12 Experts

The U.S. Department of Justice (DOJ) is holding firm on its stance that medical marijuana users should not allowed to own a gun, citing safety risks.
In a recent filing, federal attorneys argued that the <a href="https://www.benzinga.com/markets/cannabis/24/06/39488414/cannabis-guns-kentucky-2nd-amendment-meet-the-atf-if-you-say-yes-to-medical-marijuana-the-answer">ban on gun ownership</a> for cannabis users is constitutional and should remain in place. 
This aligns with federal regulations barring gun access for individuals considered potentially dangerous, such as those who are mentally ill or under the influence, <a href="https://www.marijuanamoment.net/doj-says-allowing-a-pennsylvania-prosecutor-who-uses-medical-marijuana-to-possess-a-gun-would-be-dangerous/">reported</a> Marijuana Moment.
<h3 class="wp-block-heading">Pennsylvania Prosecutor Challenges Federal Gun Ban</h3>
This filing responds to <a href="https://www.benzinga.com/markets/cannabis/24/01/36750779/guns-and-weed-conflict-heats-up-pennsylvania-da-sues-feds-over-firearms-ban-for-medical-marijuan">a lawsuit</a> by Robert Greene, the District Attorney of Warren County, Pennsylvania, who is a registered medical marijuana patient. Along with the Second Amendment Foundation, Greene filed suit against the DOJ, Attorney General Merrick Garland and other federal agencies, arguing that the ban infringes on his right to bear arms for self-defense.
The DOJ&#8217;s filing, submitted to the U.S. District Court for the Western District of Pennsylvania, seeks to dismiss Greene&#8217;s suit. 
"Marijuana's physical and mental effects impair a person's judgment, including judgment about whether to use firearms," it says.
The next step for Robert Greene's case involves a federal court decision on his request for a preliminary injunction.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37823911/cannabis-and-guns-legal-battle-heats-up-as-feds-block-weapons-sales-over-weed-smell-lawsuits-ens">Cannabis And Guns: Legal Battle Heats Up As Feds Block Weapons Sales Over Weed Smell, Lawsuits Ensue</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Contradictory Ruling In Texas Gun &amp; Cannabis Rights Case</h3>
Greene's case is not the only legal battle on this issue. In a separate case, the 5th U.S. Circuit Court of Appeals ruled that cannabis users cannot be barred from owning firearms.
The ruling arose from <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">the case</a> of Paola Connelly, a Texas resident whose right to bear arms was upheld despite her past marijuana use. "Marijuana user or not, Paola is a member of our political community and thus has a presumptive right to bear arms," U.S. Circuit Judge Kurt Engelhardt ruled.
The decision is significant because it aligns with <a href="https://www.benzinga.com/markets/cannabis/23/08/33719970/federal-court-strikes-down-gun-prohibition-for-cannabis-users-as-unconstitutional">a 2022 Supreme Court</a> decision stating that firearm laws should reflect historical gun ownership traditions.
While the DOJ has not commented on this ruling, it raises questions about how the federal government will address gun ownership rights among the millions of legal cannabis users nationwide.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">Cannabis Users Cannot Be Barred From Gun Ownership, U.S. Appeals Court Rules </a></li>
</ul>
Cover: AI generated image

Cannabis

Government

Regulations

Legal

Justice Department Defends Ban On Gun Ownership For Medical Cannabis Users

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) just reported results for the first quarter of 2024.<ul><li>Candel Therapeutics reported earnings per share of -28 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/cadl-stock-earnings-candel-therapeutics-for-q1-of-2024/">CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024

Candel Therapeutics GAAP EPS of -$0.28

SCWorx, Cue Health, Sensei Biotherapeutics among healthcare movers

Candel gains FDA orphan status for brain tumor candidate

Candel Therapeutics to join Russell 3000 Index

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Let me be clear: investing in <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a> isn&rsquo;t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance. Investing in A-rated biotech stocks offers high return potential if they make significant advancements in health care.



Biotech stocks represent companies that are involved in the research and development of drugs, therapies and medical devices. They include companies that work in fields such as genomics, biopharmaceuticals, bioinformatics and medical diagnostics.



A-rated biotech stocks are highly coveted because they are at the forefront &mdash; or in the midst of &mdash; groundbreaking innovation. 



A biotech company that wins regulatory approval for a new drug can see a huge increase in stock price, providing lucrative returns to investors and billions of dollars in annual profit for the company.



But remember &mdash; bringing a drug to market costs a lot of money. Biotech stocks must absorb high research and development costs through laboratory research, preclinical trials and multiple phases of clinical trials. 



It can take years to bring a drug to market, or even to get it in front of the Food and Drug Administration for approval. Any setback can derail the drug pipeline and cause the stock price to collapse.



By using the Portfolio Grader, we can identify A-rated biotech stocks based on analyst sentiment, earnings performance, growth and stock buying momentum. If you want to try your hand in the biotech sector, these A-rated biotech stocks are a good place to start.



<h2>Eli Lilly &amp; Co. (LLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/lly_eli_lilly_1600-300x169.png" alt="Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals XI"><div>Source: Jonathan Weiss / Shutterstock.com</div></div>Eli Lilly &amp; Co. (NYSE:<a href="https://investorplace.com/stock-quotes/lly-stock-quote/">LLY</a>) can arguably be considered the best biotech stock on the market right now. 



The Indianapolis-based biotech company is set to make billions of dollars a year through its weight-loss treatment drug. And now there&rsquo;s yet another catalyst that is sending LLY stock higher.



First, let&rsquo;s talk about Zepbound, which is Lilly&rsquo;s FDA-approved drug to help people lose weight. The injectable drug won FDA approval in November 2023, so Lilly is just getting started on a long run of profits. About 42% of the U.S. population is obese and the window for Lilly to profit from Zepbound is huge.



The drug in Zepbound, tirzepatide, is also used in another highly successful Lilly product called Mounjaro, which is used to treat type 2 diabetes.



The drugs are so popular that Lilly is&nbsp;<a href="https://investor.lilly.com/news-releases/news-release-details/lilly-increases-manufacturing-investment-9-billion-newest">increasing its investment</a>&nbsp;in its Indiana manufacturing facility from $3.7 billion to $9 billion to increase the production of tirzepatide and other pipeline products.



And now Lilly is set to score big on another treatment. An FDA panel voted unanimously in favor of the company&rsquo;s <a href="https://investorplace.com/2024/06/eli-lilly-stock-hits-new-52-week-high-as-fda-panel-recommends-alzheimers-drug/">donanemab&nbsp;</a>drug, which would be used to treat Alzheimer&rsquo;s. The full FDA still needs to give final approval, but the unanimous recommendation of its panel is a very good sign.



LLY stock reached a new 52-week high on the news. The stock is now up 48% on the year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Lexaria Bioscience (LEXX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2-300x169.jpg" alt="A close-up concept image of a tiny glass vial with a strand of DNA in it. best biotech stocks"><div>Source: Shutterstock</div></div>Lexaria Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/lexx-stock-quote/">LEXX</a>) is a much different biotech company than Lilly. But the company has its own wins and is worthy of its status as an A-rated biotech stock.



Lexaria developed DehydraTECH, which is a drug delivery technology that improves the way active pharmaceutical ingredients enter the bloodstream.



Lexaria says its platform promotes healthier delivery methods and increases the effectiveness of drugs that are delivered by tablets, capsules and oral suspensions.



Any drug delivery system that makes medications more effective and more tolerable to patients is going to be popular in the biotech field. 



The DehydraTECH platform increases the absorption of the drug into a patient and helps the medication take effect faster. It also reduces the need for sugar-filled products because it can mask the taste of medications.



While R&amp;D costs are still outweighing profits, there&rsquo;s good reason to be bullish on LEXX stock, which is already up 159% this year. It gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Novo Nordisk (NVO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/nvo-stock-300x169.jpg" alt="Novo Nordisk logo on a corporate building"><div>Source: joreks / Shutterstock.com</div></div>Novo Nordisk (NYSE:<a href="https://investorplace.com/stock-quotes/nvo-stock-quote/">NVO</a>) has some of the same catalysts are work that are pushing LLY stock higher. 



The European company has an injectable weight loss drug of its own, called Wegovy. Wegovy was approved in 2021 by U.S. regulators to treat weight loss and recently as also approved for treatment in the U.K.



Wegovy&rsquo;s popularity has led to shortages in some pharmacies as Novo Nordisk struggles to keep up with demand. The company&rsquo;s running its manufacturing operations 24 hours a day to meet demand.



Novo Nordisk has another huge drug on the market, Ozempic, which is a treatment for type 2 diabetes.



<a href="https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168508">Earnings for the first quarter</a> included days of 65.3 billion Danish kroner ($9.46 billion), up 22% from a year ago. Operating profit was up 27%, and net profits were up 29%.



Novo Nordisk reported earnings per share of 5.68 Danish kroner (85 cents per share), which was up 29% from a year ago.



NVO stock is up 38% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Ocugen (OCGN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/ocgn1600-2-300x169.png" alt="Person holding cellphone with webpage of US biopharmaceutical company Ocugen Inc (OCGN) on screen in front of logo Focus on center of phone display"><div>Source: Wirestock Creators / Shutterstock.com</div></div>Ocugen (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocgn-stock-quote/">OCGN</a>) is a small biotech company based in Pennsylvania. With a market capitalization of less than $400 million, Ocugen is working on developing and commercializing gene and cell therapies.



The company has a breakthrough modifier gene therapy platform that has the potential to treat multiple retinal disease with a single product, which could be highly lucrative if brought to market.



The company has <a href="https://ocugen.com/therapeutic-areas/">multiple retinal products</a> in various phases of testing in an effort to treat hard-to-treat eye disease. 



It also has a treatment in Phase 3 testing to treat knee cartilage damage and ideally help prevent osteoarthritis, and it has started on a potential inhaled vaccine that would help prevent Covid-19.



The company&rsquo;s stock will get a boost later this month when it joins the Russell 3000, an inclusion that should improve the trading volume as funds that track the index purchase OCGN shares.



The company reported <a href="https://ir.ocugen.com/news-releases/news-release-details/ocugen-provides-business-update-first-quarter-2024-financial">cash and cash equivalents</a> of $25.4 million at the end of the first quarter, with total operating expenses for the quarter of $13.2 million. 



Bringing a drug to market is expensive. But since it has FDA approval for Phase 3 trials for its retinal treatment, the company is on the verge of bringing to market a treatment that affects an estimated 300,000 people in the U.S. and Europe.



OCGN stock still trades for less than $2 per share, but probably won&rsquo;t be that low for long. The stock is up 154% so far in 2024 and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Candel Therapeutics (CADL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600-300x169.png" alt="Light blue pills on white background. Pharmaceutical industry, medical treatment, presciption drugs concept. Digital 3D render., biotech stocks, big pharma. EVAX stock"><div>Source: Hernan E. Schmidt / Shutterstock.com</div></div>Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) is a Massachusetts that works with viral immunotherapies in an effort to treat cancer. 



Its treatment platform includes combining an anti-tumor component and an immune-stimulatory component to attack malignant cells.



The company developed two clinical stage investigational viral immunotherapies designed to produce an individualized cancer response, based on genetically modified adenovirus and herpes simplex virus gene constructs, respectively.



It currently has several drug candidates in Phase 2 and Phase 3 trials, including treatments for prostate, lung and pancreatic cancer. Like Ocugen, Candel is also joining the Russell 3000 this year.



The company had <a href="https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-reports-first-quarter-2024-financial-results">cash and cash equivalents</a> of $25.7 million at the end of the first quarter, which is says will be sufficient to fund operations into the fourth quarter. R&amp;D expenses in the first quarter were only $4.1 million, while general and administrative expenses were only $3.8 million.



CADL stock soared since April and is now up more than 400% this year. It gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Teva Pharmaceutical (TEVA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/teva1600a-300x169.jpg" alt="Opioids Made TEVA Stock Untouchable But Things Seem to be Changing"><div>Source: JHVEPhoto / Shutterstock.com</div></div>Teva Pharmaceutical (NYSE:<a href="https://investorplace.com/stock-quotes/teva-stock-quote/">TEVA</a>) is a leading manufacturer of generic pharmaceuticals. Once a company loses exclusivity in a drug several years after bringing it to market, any drug manufacturer can offer a generic equivalent that can be sold for less than the name-brand drug. That&rsquo;s where Teva comes in.



Teva says nearly 200 million people around the world use drugs that it manufacturers, with production sites in 53 locations spanning 33 countries. The company says its generic equivalents help patients save more than $40 billion a year in health care costs.



One of its <a href="https://investorplace.com/2024/02/teva-stock-pops-4-as-teva-receives-fda-approval/">newest treatments</a> is with a strategic partner, Alvotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/alvo-stock-quote/">ALVO</a>), which won FDA approval for an injectable drug to be used as an alternative to Humira, which is a prescription drug to treat rheumatoid arthritis. 



Humira is made by AbbVie (NYSE:<a href="https://investorplace.com/stock-quotes/abbv-stock-quote/">ABBV</a>), and was one of the biggest pharmaceutical products in the world last year with $12.2 billion in sales.



Revenue for the first quarter was $1.72 billion, up from $1.67 billion a year ago. The company reported profits of $350 million, up from $338 million in the first quarter of 2023.



TEVA stock is up 64% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>GSK (GSK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/gsk-stock-1-300x169.jpg" alt="A GlaxoSmithKline (GSK) office in London."><div>Source: Willy Barton / Shutterstock.com</div></div>GSK (NYSE:<a href="https://investorplace.com/stock-quotes/gsk-stock-quote/">GSK</a>), also known as GlaxoSmithKline, is a British biotech company that focuses on making treatments for infectious diseases, HIV, immunology and respiratory conditions and cancer.



Its top drugs include Calpol, which treats cold systems in infants; Ceftum, an antibiotic, and Neosporin, which in cream form treats skin pain, itches and wounds.



The company has more than 70 vaccine candidates and specialty medications in clinical development, with 18 in Phase 3 testing.



Sales in the first quarter were 7.4 billion British pounds ($9.46 billion), up 10% from a year ago. Profits were 2.4 billion British pounds, up 27% from a year ago.



GSK stock is up 11% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



On the date of publication, Louis Navellier had long positions in NVO and LLY. Louis Navellier did not have (either directly or indirectly) any other positions in the securities mentioned in this article.



The InvestorPlace Research Staff member primarily responsible for this article did not hold (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-a-rated-biotech-stocks-worth-betting-on-in-june/">7 A-Rated Biotech Stocks Worth Betting on in June</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 A-Rated Biotech Stocks Worth Betting on in June

Candel Therapeutics: Innovative Cancer Therapies, But Short Cash Runway

3 Biotech Names With Potential Catalysts By Year End

Candel Therapeutics GAAP EPS of -$0.74

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) just reported results for the second quarter of 2024.<ul><li>Candel Therapeutics reported earnings per share of -74 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/cadl-stock-earnings-candel-therapeutics-for-q2-of-2024/">CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024

ABBV

AKAN

AMGN

BIIB

FNCH

GNLX

HLTH

LEXX

OCGN

ONMD

RCKT

SNSE

TEVA

VRDN

WORX

Screenshot 2024-06-13 at 5.29.56 PM

Biotech

Candel Therapeutics&#39; (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Screenshot 2024-06-06 at 5.30.54 PM

Candel Therapeutics&#39; (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers

Screenshot 2024-05-31 at 5.22.29 PM

Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer

Screenshot 2024-04-04 at 9.54.11 PM

Chief Science Officer Talks Innovation In Cancer Research

Screenshot 2024-03-25 at 6.13.53 PM

The CEO Of This Innovative BioPharma Is Bringing Light To Cancer Research

Screenshot 2024-03-14 at 5.26.26 PM

Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors

Screenshot 2024-03-05 at 6.31.45 PM

CGON

CLDI

TOVX

Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology

Screenshot 2024-02-27 at 6.29.08 PM

Moving Fast: Candel&#39;s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer

Health Care

Press Releases

Candel Therapeutics to Join Russell 3000® Index

Opinion

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

Small Cap

Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates

Earnings

Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Management

Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors

Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting

FGEN

HALO

MIST

MRUS

ONCY

REGN

RHHBY

TSX:ONC

VSTM

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Atossa Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

Cellectis S.A. - American Depositary Shares

Cellectis

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Gossamer Bio

Inhibrx Biosciences

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Macrogenics

Nanobiotix

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Poseida Therapeutics, Inc. - Common Stock

Poseida Therapeutics

Pyxis Oncology

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

2seventy bio

Vaxart

XBiotech

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

HC Wainwright & Co.

BMO Capital

Credit Suisse

미국 주식 시장은 목요일에 하락하며, 다우존스 지수는 1.35% 하락한 38,596.98에 도달했다. 나스닥과 S&amp;P 500도 각각 1.4% 하락한 16,049.08과 1.23% 하락한 5,147.21을 기록했다. 전체 시장의 하락에도 불구하고, 일부 종목은 소매 트레이더와 투자자들의 주목을 끌었다.
하루 내내 소매 트레이더와 투자자들의 관심을 끌은 주요 주식은 다음과 같다:
포드 자동차(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)는 3.22% 하락한 13.21달러에서 마감했다. 이 주식의 장중 최고가와 최저가는 각각 13.95달러와 13.17달러로, 52주간의 변동폭은 9.63달러에서 15.42달러다. 포드는 온타리오 주 오크빌 조립 단지에서 신형 3열 전기차 출시를 2025년에서 2027년으로 <a href="https://www.benzinga.com/markets/equities/24/04/38093618/ford-slows-down-electric-suv-production-amid-demand-concerns">연기한다고 발표했다</a>.
캔델 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CADL#NASDAQ">CADL</a>)은 280.95%의 상당한 폭의 급등을 기록한 6.4달러에 마감했다. 이 주식의 장중 최고가는 7.65달러로, 52주간의 변동폭은 0.66달러에서 7.65달러다. 이 회사는 현재 진행 중인 CAN-2409의 2상 임상시험에서 업데이트된 <a href="https://www.benzinga.com/general/biotech/24/04/38092867/after-brain-cancer-data-candel-therapeutics-shares-good-news-from-pancreatic-cancer-study">중간 생존 데이터를 발표했다</a>.
엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)는 3.44% 하락한 859.05달러에 마감했다. 이 주식의 장중 최고가와 최저가는 각각 906.34달러와 858.8달러, 52주간 범위는 262.2달러에서 974.00달러다. 엔비디아 주가는 <a href="https://www.benzinga.com/news/24/04/38083172/taiwan-earthquake-alarms-gene-munster-the-only-thing-that-can-slow-ai-in-the-near-term-is-impact-on" target="_blank" rel="noopener">대만의 강력한 지진</a>으로 인한 공급망 제약에 대한 우려로 인해 전일 하락한 후 목요일 개장 벨이 울리기 전에 <a href="https://www.benzinga.com/markets/equities/24/04/38087829/why-is-nvidia-stock-rising-premarket-after-a-pullback" target="_blank" rel="noopener">높게 거래</a>되었다.
팔란티어 테크놀로지 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)은 0.97% 하락한 22.48달러에 마감했다. 이 주식의 장중 최고가와 최저가는 각각 24.1달러와 22.4달러, 52주간의 변동폭은 7.28달러에서 27.50달러다. Palantir 주가는 회사가 안전한 클라우드 및 AI 솔루션을 제공하기 위해 <a href="https://www.benzinga.com/markets/equities/24/04/38091895/whats-going-on-with-palantir-oracle-shares-after-they-inked-partnership">오라클과의 파트너십을 체결</a>한 후 목요일 상승세로 거래되었다.
테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)는 1.62% 상승한 171.11달러에 마감했다. 이 주식의 장중 최고가와 최저가는 각각 177.19달러와 168.01달러, 52주간의 변동폭은 152.37달러에서 299.29달러다. 최근의 하락에도 불구하고 한 분석가는 테슬라 주식의 <a href="https://www.benzinga.com/markets/equities/24/04/38083793/tesla-draws-79-upside-prediction-from-analyst-betting-on-impressive-full-self-driving">상당한 상승을 예상</a>했습니다.
Shutterstock의 Phongphan 씨 촬영
빠져나올 수 없는 <a href="Premarket Movers &amp; News">최고의 조기장세 동향과 뉴스와 함께</a> Benzinga의 도움을 받아 오늘의 거래를 준비하세요.
다음 기사 읽기: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38062216/bitcoin-ethereum-dogecoin-dip-amid-high-selling-pressure-analyst-says-king-crypto-will-not?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">비트코인, 이더리움, 도지코인의 고점 갱신은 단기 내 남아있지 않을 것</a>
<div style="font-family: 'Lato', sans-serif;">
<div>
<hr style="border: 0; height: 5px; background: #225aa9;" />
<div style="background-color: #f5f5f5; background-position: center; background-size: cover; justify-content: center;"></div>
<a class="ticker" style="color: #225aa9; text-decoration: none;" href="https://www.benzinga.com/ko/author/shivdeep-dhaliwal" rel="noopener">Shivdeep Dhaliwal</a>의 편집
<hr style="border: 0; height: 1px; background: #225aa9;" />
GPT-4 기반의 Benzinga Neuro 콘텐츠 생성 시스템은 네이티브 데이터, API 등 벤징가 생태계의 다양한 정보들을 활용하여 시기적절한 다양한 이야기를 제공합니다. <a style="color: #225aa9; text-decoration: none;" href="https://www.benzinga.com/author/benzinga-neuro" rel="noopener">더 알아보기</a>
<hr style="border: 0; height: 5px; background: #225aa9;" />
</div>
</div>

Comments

Candel Therapeutics

뉴스

에 대한 최신 뉴스 Candel Therapeutics (NASDAQ:CADL) 주식

금요일, 4월 05, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌